Can melatonin be used as a marker for neonatal sepsis
Franquet, E
Potential mechanisms include rapid blood glucose fluctuations, dehydration from reduced appetite, changes in vascular tone, and dose escalation speed
Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists -Potential Game Changers in the Treatment of Glaucoma
Clinical trials found an average weight loss of 17.5% after 24 weeks, increasing to 24.2% after 48 weeks
Four of the 36 patients tested experienced mild adverse events such as blepharitis, keratitis, hyperemia, and ocular irritation, all of which resolved within 72 h